HUMAN ALBUMIN 5% (CSL Behring) Infusion

Albumin Human 5%
50mg/ml
CSL BEHRING AG
Pack size 250ml Glass Bottle
Dispensing mode POM
Source SWITZERLAND
AgentModern Pharmaceutical Co.
Retail Price 192.50 AED

Indications

HUMAN ALBUMIN 5% (CSL Behring) Infusion is used for: Burns, Hypovolemia, Hypoalbuminemia, Adult Respiratory Distress Syndrome, Nephrosis, Cardiopulmonary Bypass Surgery, Hemolytic Disease of the Newborn, Ovarian Hyperstimulation Syndrome

Adult Dose

Adult: Initially, 25 g of albumin, adjusted according to patient's response. Usual rates of infusion: Up to 5 ml/minute (5% solution). Intravenous Hypoproteinaemia Adult: Up to 2 g/kg daily. Usual rates of infusion: Up to 5 ml/minute (5% solution). Special Populations: Volume admin and rate of infusion must always be individualised according to situation and response. Usual rates of infusion are up to 5 ml/min (5% soln).

Child Dose

Child: Up to 1 g/kg, adjusted according to patient's response. Usual rates of infusion: Up to 5 ml/minute (5% solution). Intravenous Neonatal hyperbilirubinaemia Child: 1 g/kg of albumin before exchange transfusion. Usual rates of infusion: Up to 5 ml/minute (5% solution). Special Populations: Volume admin and rate of infusion must always be individualised according to situation and response. Usual rates of infusion are up to 5 ml/min (5% soln).

Renal Dose

Administration

Contra Indications

Cardiac failure, severe anaemia, history of hypersensitivity, parenteral nutrition.

Precautions

Hypertension or low cardiac reserve; additional fluids for dehydrated patients. Monitor for signs of cardiac overload in injured or postoperative patients. May carry risk of viral transmission. Volume admin and rate of infusion must always be individualised according to situation and response. Pregnancy, lactation. Lactation: Endogenous albumin found in breast milk; compatible.

Pregnancy-Lactation

Pregnancy category: C Lactation: Endogenous albumin found in breast milk; compatible

Interactions

Albumin solution should not be mixed by protein hydrolysates or alcoholic solutions. Risk of atypical reactions to ACE inhibitors in patients undergoing therapeutic plasma exchange with albumin human replacement.

Adverse Effects

Side effects of Albumin Human 5% : Allergic reactions, nausea, vomiting, increased salivation, fever and chills; vascular overload, haemodilution and pulmonary oedema. Potentially Fatal: Anaphylactic shock.

Mechanism of Action

Human albumin increases intravascular oncotic pressure and causes movement of fluids from interstitial into intravascular space. Human albumin solutions are available in various concentrations. Solutions containing 5% human albumin are usually used in hypovolemic patients, whereas more concentrated 25% solutions are recommended in patients in whom fluid and sodium intake must be minimised e.g. patients with hypoproteinaemia or cerebral oedema or in paediatric patients.

Note

HUMAN ALBUMIN 5% (CSL Behring) 50mg/ml Infusion manufactured by CSL BEHRING AG. Its generic name is Albumin Human 5%. HUMAN ALBUMIN 5% (CSL Behring) is availble in United Arab Emirates. Farmaco UAE drug index information on HUMAN ALBUMIN 5% (CSL Behring) Infusion is not intended for diagnosis, medical advice or treatment; neither intended to be a substitute for the exercise of professional judgment.

Some other brands of Albumin Human 5% :